{"schema_version":"1","generated_at":"2026-11-08T00:09:15.419Z","data_as_of":null,"url":"https://www.findmykol.com/kol/prerna-mewawalla","json_url":"https://www.findmykol.com/kol/prerna-mewawalla/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"prerna-mewawalla","name":"Prerna Mewawalla","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Pittsburgh","state":"PA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1689804510","orcid":"0009-0008-7464-6898","openalex":"A5044628707"},"summary":"Prerna Mewawalla is an Oncology physician. OpenAlex indexes 133 publications with 337 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":133,"cited_by_count":337,"h_index":9,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":12,"program_years":{"first":2021,"last":null},"rows_total":21,"shown":3,"withheld":18,"rows":[{"payer":"Pfizer","program_year":2025,"amount_usd":135146.71,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1689804510"},{"payer":"Janssen","program_year":2025,"amount_usd":42012,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1689804510"},{"payer":"PFIZER INC.","program_year":2025,"amount_usd":15248.6,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1689804510"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1689804510","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis","year":2026,"journal":"Current Oncology","source_url":"https://doi.org/10.3390/curroncol33050249","status":"verified"},{"title":"A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment—USMIRC Group","year":2026,"journal":"Cancers","source_url":"https://doi.org/10.3390/cancers18050740","status":"verified"},{"title":"Pre-Transplant Marrow CD3+ T cell Status and Outcomes in Newly Diagnosed Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplantation","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.12.631","status":"verified"},{"title":"Talquetamab in heavily pretreated patients with multiple myeloma, including BCMA-refractory","year":2025,"journal":"Blood Immunology & Cellular Therapy","source_url":"https://doi.org/10.1016/j.bict.2025.100001","status":"verified"},{"title":"A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma","year":2025,"journal":"Blood Cancer Journal","source_url":"https://doi.org/10.1038/s41408-025-01226-8","status":"verified"}],"source":"works"},"contact":{"address_1":"4815 LIBERTY AVE STE 322","city":"Pittsburgh","state":"PA","zip":"152242156","phone":"412-578-4484","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1689804510","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":18,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-10-02","provider_certified":"2020-10-02","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}